These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18365833)

  • 1. Role of the NF-kappaB axis in immune modulation of osteoclasts and bone loss.
    Abu-Amer Y; Darwech I; Otero J
    Autoimmunity; 2008 Apr; 41(3):204-11. PubMed ID: 18365833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF-kappaB modulators in osteolytic bone diseases.
    Xu J; Wu HF; Ang ES; Yip K; Woloszyn M; Zheng MH; Tan RX
    Cytokine Growth Factor Rev; 2009 Feb; 20(1):7-17. PubMed ID: 19046922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of nuclear factor-kappaB in the immune system and bone.
    Jimi E; Ghosh S
    Immunol Rev; 2005 Dec; 208():80-7. PubMed ID: 16313342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cathepsin G enhances mammary tumor-induced osteolysis by generating soluble receptor activator of nuclear factor-kappaB ligand.
    Wilson TJ; Nannuru KC; Futakuchi M; Sadanandam A; Singh RK
    Cancer Res; 2008 Jul; 68(14):5803-11. PubMed ID: 18632634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nuclear factor-kappaB inhibitor BAY11-7082 inhibits interactions between human endothelial cells, T cells, and monocytes.
    Zhu B; Liu Z; Wang P; Wu C; Xu H
    Transplant Proc; 2008 Oct; 40(8):2724-8. PubMed ID: 18929846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baicalein inhibits osteoclast differentiation and induces mature osteoclast apoptosis.
    Kim MH; Ryu SY; Bae MA; Choi JS; Min YK; Kim SH
    Food Chem Toxicol; 2008 Nov; 46(11):3375-82. PubMed ID: 18786594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory interventions of NF-kappaB signaling: potential applications and risks.
    Uwe S
    Biochem Pharmacol; 2008 Apr; 75(8):1567-79. PubMed ID: 18070616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of osteoclast function in bone by the immune system.
    Quinn JM; Saleh H
    Mol Cell Endocrinol; 2009 Oct; 310(1-2):40-51. PubMed ID: 19056462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with N-tosyl-l-phenylalanine chloromethyl ketone after the onset of collagen-induced arthritis reduces joint erosion and NF-kappaB activation.
    Choi J; Ha KH; Byun MS; Min SY; Park MJ; Park HS; Oh HJ; Ju JH; Kim HY; Jue DM
    Eur J Pharmacol; 2008 Oct; 595(1-3):108-13. PubMed ID: 18706406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory effects of plumbagin are mediated by inhibition of NF-kappaB activation in lymphocytes.
    Checker R; Sharma D; Sandur SK; Khanam S; Poduval TB
    Int Immunopharmacol; 2009 Jul; 9(7-8):949-58. PubMed ID: 19374955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SIRT1 longevity factor suppresses NF-kappaB -driven immune responses: regulation of aging via NF-kappaB acetylation?
    Salminen A; Kauppinen A; Suuronen T; Kaarniranta K
    Bioessays; 2008 Oct; 30(10):939-42. PubMed ID: 18800364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling.
    Yi T; Lee HL; Cha JH; Ko SI; Kim HJ; Shin HI; Woo KM; Ryoo HM; Kim GS; Baek JH
    J Cell Physiol; 2008 Nov; 217(2):409-22. PubMed ID: 18543257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoclast culture and resorption assays.
    Bradley EW; Oursler MJ
    Methods Mol Biol; 2008; 455():19-35. PubMed ID: 18463808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF-kappaB in inflammatory bowel disease.
    Atreya I; Atreya R; Neurath MF
    J Intern Med; 2008 Jun; 263(6):591-6. PubMed ID: 18479258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoimmunology--the hidden immune regulation of bone.
    Caetano-Lopes J; Canhão H; Fonseca JE
    Autoimmun Rev; 2009 Jan; 8(3):250-5. PubMed ID: 18722561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caffeic acid phenethyl ester inhibits osteoclastogenesis by suppressing NF kappaB and downregulating NFATc1 and c-Fos.
    Ha J; Choi HS; Lee Y; Lee ZH; Kim HH
    Int Immunopharmacol; 2009 Jun; 9(6):774-80. PubMed ID: 19285574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paeonol inhibits RANKL-induced osteoclastogenesis by inhibiting ERK, p38 and NF-kappaB pathway.
    Tsai HY; Lin HY; Fong YC; Wu JB; Chen YF; Tsuzuki M; Tang CH
    Eur J Pharmacol; 2008 Jun; 588(1):124-33. PubMed ID: 18495114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic protein complexes regulate NF-kappaB signaling.
    Wegener E; Krappmann D
    Handb Exp Pharmacol; 2008; (186):237-59. PubMed ID: 18491055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory NF-kappaB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production.
    Tsai J; Zhang R; Qiu W; Su Q; Naples M; Adeli K
    Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1287-98. PubMed ID: 19342510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual roles of NF-kappaB in cell survival and implications of NF-kappaB inhibitors in neuroprotective therapy.
    Qin ZH; Tao LY; Chen X
    Acta Pharmacol Sin; 2007 Dec; 28(12):1859-72. PubMed ID: 18031598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.